Suppression of babesiosis in BCG-infected mice and its correlation with tumor inhibition
- PMID: 330411
- PMCID: PMC421139
- DOI: 10.1128/iai.17.2.430-438.1977
Suppression of babesiosis in BCG-infected mice and its correlation with tumor inhibition
Abstract
Infection of mice with Bacillus Calmette-Guérin (BCG) provided good protection against Babesia species. The intensity and duration of this protection was similar to that established after natural recovery from babesiosis. It developed too soon after the first exposure to the parasite, and was too radioresistant, to be attributable to specific antibody production. In addition, the parasites degenerated within circulating erythrocytes. This phenomenon is inconsistent with phagocytosis or lysis of parasites or parasitized cells, or prevention of entry of parasites into erythrocytes, causing the observed protection. Hence the phenomenon is best explained by the release of a nonspecific mediator that can limit multiplication of parasites within erythrocytes. These results not only throw light on mechanisms of immunity against hemoprotozoa. There are many points of similarity between the nonspecific protection BCG and Corynebactium parvum provide against Babesia species and inhibition of tumor growth by these agents. Therefore, babesiosis in mice may be a convenient experimental model for assessing stimulation of the mononuclear phagocyte system, which appears to be the basis of nonspecific immunity against bacteria, parasites, and tumors.
Similar articles
-
Harnessing Mycobacterium bovis BCG Trained Immunity to Control Human and Bovine Babesiosis.Vaccines (Basel). 2022 Jan 14;10(1):123. doi: 10.3390/vaccines10010123. Vaccines (Basel). 2022. PMID: 35062784 Free PMC article. Review.
-
Protection of mice against Babesia spp. and Plasmodium spp. with killed Corynebacterium parvum.Parasitology. 1977 Feb;74(1):9-18. doi: 10.1017/s003118200004748x. Parasitology. 1977. PMID: 320544
-
Bovine babesiosis: Cattle protected in the field with a frozen vaccine containing Babesia bovis and Babesia bigemina cultured in vitro with a serum-free medium.Parasitol Int. 2018 Apr;67(2):190-195. doi: 10.1016/j.parint.2017.11.004. Epub 2017 Nov 16. Parasitol Int. 2018. PMID: 29155165
-
Protection of mice against Babesia and Plasmodium with BCG.Nature. 1976 Jan 29;259(5541):309-11. doi: 10.1038/259309a0. Nature. 1976. PMID: 765838 No abstract available.
-
Bovine babesiosis: a review of recent advances.Arch Med Res. 1994 Summer;25(2):241-5. Arch Med Res. 1994. PMID: 7919821 Review.
Cited by
-
Protection of mice against haemoprotozoan Babesia microti with Brucella abortus strain 19.Clin Exp Immunol. 1978 Mar;31(3):518-23. Clin Exp Immunol. 1978. PMID: 95914 Free PMC article.
-
Human malarial disease: a consequence of inflammatory cytokine release.Malar J. 2006 Oct 10;5:85. doi: 10.1186/1475-2875-5-85. Malar J. 2006. PMID: 17029647 Free PMC article. Review.
-
Host defenses in murine malaria: nonspecific resistance to Plasmodium berghei generated in response to Mycobacterium bovis infection or Corynebacterium parvum stimulation.Infect Immun. 1981 Jul;33(1):199-211. doi: 10.1128/iai.33.1.199-211.1981. Infect Immun. 1981. PMID: 7021424 Free PMC article.
-
Role of T cells in preventing transmission of rodent malaria.Immunology. 1985 Sep;56(1):1-7. Immunology. 1985. PMID: 3876268 Free PMC article.
-
The experimental and clinical use of immune-modulating drugs in the prophylaxis and treatment of infections.Infection. 1984 Mar-Apr;12(2):157-66. doi: 10.1007/BF01641705. Infection. 1984. PMID: 6203843
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources